{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:52:35Z","timestamp":1791075155791,"version":"4.1.0"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:00:00Z","timestamp":1790985600000},"content-version":"vor","delay-in-days":11,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-07285-6","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:45:37Z","timestamp":1790045137000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Obstetric and thrombotic outcomes among pregnant patients with myeloproliferative neoplasms: a propensity score matched real-world analysis"],"prefix":"10.1007","volume":"105","author":[{"given":"Nikhil","family":"Vojjala","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sambasiva Rao","family":"Srungavarapu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sushmitha","family":"Nanjareddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mani Vignesh","family":"Kannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishab","family":"Prabhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camelia","family":"Arsene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geetha","family":"Krishnamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijendra","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"issue":"22","key":"7285_CR1","doi-asserted-by":"publisher","first-page":"2168","DOI":"10.1056\/NEJMra1406186","volume":"376","author":"JL Spivak","year":"2017","unstructured":"Spivak JL (2017) Myeloproliferative Neoplasms. N Engl J Med 376(22):2168\u20132181","journal-title":"N Engl J Med"},{"issue":"4","key":"7285_CR2","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1002\/ajh.24288","volume":"91","author":"T Barbui","year":"2016","unstructured":"Barbui T, Thiele J, Vannucchi AM, Tefferi A (2016) Myeloproliferative neoplasms: Morphology and clinical practice. Am J Hematol 91(4):430\u2013433","journal-title":"Am J Hematol"},{"issue":"1","key":"7285_CR3","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1111\/bjh.14289","volume":"175","author":"S Alimam","year":"2016","unstructured":"Alimam S, Bewley S, Chappell LC, Knight M, Seed P, Gray G et al (2016) Pregnancy outcomes in myeloproliferative neoplasms: UK prospective cohort study. Br J Haematol 175(1):31\u201336","journal-title":"Br J Haematol"},{"issue":"10","key":"7285_CR4","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41375-022-01688-w","volume":"36","author":"AR Landtblom","year":"2022","unstructured":"Landtblom AR, Andersson TM, Johansson ALV, Wendel SB, Lundberg FE, Samuelsson J et al (2022) Pregnancy and childbirth outcomes in women with myeloproliferative neoplasms-a nationwide population-based study of 342 pregnancies in Sweden. Leukemia 36(10):2461\u20132467","journal-title":"Leukemia"},{"issue":"7895","key":"7285_CR5","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1038\/s41586-021-04312-6","volume":"602","author":"N Williams","year":"2022","unstructured":"Williams N, Lee J, Mitchell E, Moore L, Baxter EJ, Hewinson J et al (2022) Life histories of myeloproliferative neoplasms inferred from phylogenies. Nature 602(7895):162\u20138","journal-title":"Nature"},{"issue":"16","key":"7285_CR6","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1182\/blood.2022017416","volume":"141","author":"J How","year":"2023","unstructured":"How J, Garcia JS, Mullally A (2023) Biology and therapeutic targeting of molecular mechanisms in MPNs. Blood 141(16):1922\u20131933","journal-title":"Blood"},{"issue":"3","key":"7285_CR7","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1002\/ajh.26067","volume":"96","author":"N Gangat","year":"2021","unstructured":"Gangat N, Tefferi A (2021) Myeloproliferative neoplasms and pregnancy: Overview and practice recommendations. Am J Hematol 96(3):354\u2013366","journal-title":"Am J Hematol"},{"issue":"3","key":"7285_CR8","doi-asserted-by":"publisher","first-page":"273","DOI":"10.4037\/aacnacc2018911","volume":"29","author":"NH Troiano","year":"2018","unstructured":"Troiano NH (2018) Physiologic and Hemodynamic Changes During Pregnancy. AACN Adv Crit Care 29(3):273\u2013283","journal-title":"AACN Adv Crit Care"},{"issue":"1","key":"7285_CR9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1080\/14767058.2018.1484097","volume":"33","author":"J Lapoirie","year":"2020","unstructured":"Lapoirie J, Contis A, Guy A, Lifermann F, Viallard JF, Sentilhes L et al (2020) Management and outcomes of 27 pregnancies in women with myeloproliferative neoplasms. J Matern Fetal Neonatal Med 33(1):49\u201356","journal-title":"J Matern Fetal Neonatal Med"},{"issue":"9","key":"7285_CR10","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1182\/blood.2023020729","volume":"143","author":"S Robinson","year":"2024","unstructured":"Robinson S, Ragheb M, Harrison C (2024) How I treat myeloproliferative neoplasms in pregnancy. Blood 143(9):777\u201385","journal-title":"Blood"},{"issue":"4","key":"7285_CR11","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/bjh.16453","volume":"189","author":"SE Robinson","year":"2020","unstructured":"Robinson SE, Harrison CN (2020) How we manage Philadelphia-negative myeloproliferative neoplasms in pregnancy. Br J Haematol 189(4):625\u2013634","journal-title":"Br J Haematol"},{"issue":"2","key":"7285_CR12","doi-asserted-by":"publisher","DOI":"10.1093\/jamiaopen\/ooad035","volume":"6","author":"MB Palchuk","year":"2023","unstructured":"Palchuk MB, London JW, Perez-Rey D, Drebert ZJ, Winer-Jones JP, Thompson CN et al (2023) A global federated real-world data and analytics platform for research. JAMIA Open 6(2):ooad035","journal-title":"JAMIA Open"},{"issue":"1","key":"7285_CR13","doi-asserted-by":"publisher","DOI":"10.1080\/07853890.2026.2616549","volume":"58","author":"TL Lin","year":"2026","unstructured":"Lin TL, Chen YJ, Wu CY (2026) Choosing real-world data for clinical and epidemiological research: methodological lessons from NHIRD and TriNetX-A narrative review. Ann Med 58(1):2616549","journal-title":"Ann Med"},{"issue":"1","key":"7285_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1182\/hematology.2024000578","volume":"2024","author":"J How","year":"2024","unstructured":"How J, Hobbs G (2024) Pregnancy: MPN management before, during, and after pregnancy. Hematology Am Soc Hematol Educ Program 2024(1):541\u20136","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"Suppl 1","key":"7285_CR15","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0049-3848(13)70011-2","volume":"131","author":"N Lavi","year":"2013","unstructured":"Lavi N, Brenner B, Avivi I (2013) Management of pregnant women with myeloproliferative neoplasms. Thromb Res 131(Suppl 1):S11\u2013S13","journal-title":"Thromb Res"},{"issue":"1","key":"7285_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s13045-020-00995-y","volume":"13","author":"S Venugopal","year":"2020","unstructured":"Venugopal S, Mascarenhas J (2020) Novel therapeutics in myeloproliferative neoplasms. J Hematol Oncol 13(1):162","journal-title":"J Hematol Oncol"},{"issue":"11","key":"7285_CR17","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1038\/leu.2008.280","volume":"22","author":"JJ Kiladjian","year":"2008","unstructured":"Kiladjian JJ, Chomienne C, Fenaux P (2008) Interferon-alpha therapy in bcr-abl-negative myeloproliferative neoplasms. Leukemia 22(11):1990\u20131998","journal-title":"Leukemia"},{"key":"7285_CR18","doi-asserted-by":"crossref","unstructured":"Xu J, Murphy SL, Kochanek KD, Arias E (2022) Mortality in the United States, 2021. NCHS Data Brief. (456):1\u20138","DOI":"10.15620\/cdc:122516"},{"issue":"10","key":"7285_CR19","doi-asserted-by":"publisher","first-page":"e1912666","DOI":"10.1001\/jamanetworkopen.2019.12666","volume":"2","author":"D Maze","year":"2019","unstructured":"Maze D, Kazi S, Gupta V, Malinowski AK, Fazelzad R, Shah PS et al (2019) Association of treatments for myeloproliferative neoplasms during pregnancy with birth rates and maternal outcomes: a systematic review and meta-analysis. JAMA Netw Open 2(10):e1912666","journal-title":"JAMA Netw Open"},{"issue":"8","key":"7285_CR20","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1001\/jama.2024.25349","volume":"333","author":"A Tefferi","year":"2025","unstructured":"Tefferi A, Gangat N, Loscocco GG, Guglielmelli P, Szuber N, Pardanani A et al (2025) Essential thrombocythemia: a review. JAMA 333(8):701\u201314","journal-title":"JAMA"},{"issue":"5","key":"7285_CR21","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000882","volume":"7","author":"K Wille","year":"2023","unstructured":"Wille K, Brouka M, Bernhardt J, R\u00fcfer A, Niculescu-Mizil E, Gotic M et al (2023) Outcome of 129 pregnancies in polycythemia vera patients: a report of the European LeukemiaNET. Hemasphere 7(5):e882","journal-title":"Hemasphere"},{"issue":"1","key":"7285_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1370\/afm.668","volume":"5","author":"V Snow","year":"2007","unstructured":"Snow V, Qaseem A, Barry P, Hornbake ER, Rodnick JE, Tobolic T et al (2007) Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Ann Fam Med 5(1):74\u201380","journal-title":"Ann Fam Med"},{"issue":"9","key":"7285_CR23","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.6004\/jnccn.2022.0046","volume":"20","author":"AT Gerds","year":"2022","unstructured":"Gerds AT, Gotlib J, Ali H, Bose P, Dunbar A, Elshoury A et al (2022) Myeloproliferative Neoplasms, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw 20(9):1033\u20131062","journal-title":"J Natl Compr Canc Netw"},{"issue":"11","key":"7285_CR24","doi-asserted-by":"publisher","first-page":"e443","DOI":"10.3324\/haematol.2015.131458","volume":"100","author":"E Rumi","year":"2015","unstructured":"Rumi E, Bertozzi I, Casetti IC, Roncoroni E, Cavalloni C, Bellini M et al (2015) Impact of mutational status on pregnancy outcome in patients with essential thrombocytemia. Haematologica 100(11):e443\u2013e445","journal-title":"Haematologica"},{"issue":"2","key":"7285_CR25","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1182\/blood-2007-01-071068","volume":"110","author":"F Passamonti","year":"2007","unstructured":"Passamonti F, Randi ML, Rumi E, Pungolino E, Elena C, Pietra D et al (2007) Increased risk of pregnancy complications in patients with essential thrombocythemia carrying the JAK2 (617V\u2009>\u2009F) mutation. Blood 110(2):485\u2013489","journal-title":"Blood"},{"key":"7285_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.leukres.2020.106459","volume":"98","author":"J How","year":"2020","unstructured":"How J, Leiva O, Bogue T, Fell GG, Bustoros MW, Connell NT et al (2020) Pregnancy outcomes, risk factors, and cell count trends in pregnant women with essential thrombocythemia. Leuk Res 98:106459","journal-title":"Leuk Res"},{"issue":"5","key":"7285_CR27","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1007\/s12185-022-03336-6","volume":"115","author":"Y Edahiro","year":"2022","unstructured":"Edahiro Y (2022) Treatment options and pregnancy management for patients with PV and ET. Int J Hematol 115(5):659\u2013671","journal-title":"Int J Hematol"},{"key":"7285_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.tru.2023.100154","volume":"14","author":"B Liu","year":"2024","unstructured":"Liu B, Hadzi-Tosev M, Eisa K, Liu Y, Lucier KJ, Garg A et al (2024) Accuracy of venous thromboembolism ICD-10 codes: a systematic review and meta-analysis. Thromb Updat 14:100154","journal-title":"Thromb Updat"},{"key":"7285_CR29","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.thromres.2020.02.023","volume":"189","author":"C Baumgartner","year":"2020","unstructured":"Baumgartner C, Go AS, Fan D, Sung SH, Witt DM, Schmelzer JR et al (2020) Administrative codes inaccurately identify recurrent venous thromboembolism: the CVRN VTE study. Thromb Res 189:112\u20138","journal-title":"Thromb Res"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-07285-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07285-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-07285-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T00:02:35Z","timestamp":1791072155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-07285-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":29,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,11]]}},"alternative-id":["7285"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-07285-6","relation":{},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"assertion":[{"value":"8 August 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 September 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethical statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Patient consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"439"}}